NeuroOne Medical Technologies to Present at Key Neurology Conferences

NeuroOne Medical Technologies Corporation has announced its participation in two significant medical industry conferences in December 2025. The company, which focuses on improving surgical care options for patients with neurological disorders, will present at both the American Epilepsy Society Annual Meeting and the CNS Drug Delivery Summit.

The American Epilepsy Society 2025 Annual Meeting will take place in Atlanta, Georgia from December 5th through December 9th. This conference brings together healthcare providers, scientists, advocates, industry professionals, and other experts dedicated to improving outcomes for people with epilepsy. More information about the event can be found at https://www.aesnet.org/meetings_events/annual_meeting.

Following the AES meeting, NeuroOne will participate in the CNS Drug Delivery Summit in Boston, Massachusetts from December 9th through 11th. This seventh annual summit will gather over 100 industry experts including neuroscientists, chemists, device engineers, conjugation scientists, DMPK experts, and delivery specialists. The conference focuses on developing cutting-edge strategies to address the unique challenges in delivering treatments to the brain. Conference details are available at https://www.cnsdrugdelivery.com.

These conference participations demonstrate NeuroOne's ongoing commitment to advancing neurological care through collaboration with leading experts in the field. The company's focus on developing minimally invasive and high-definition solutions for EEG recording, monitoring, ablation, drug delivery, and stimulation aligns with the objectives of both conferences. NeuroOne's technologies aim to improve patient outcomes while reducing procedural costs for conditions including epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain resulting from failed back surgeries.

The company's presence at these prestigious medical conferences provides opportunities to share recent developments and collaborate with other professionals dedicated to neurological care advancement. Participation in such events supports NeuroOne's mission to enhance treatment options for patients suffering from various neurological disorders through innovative medical technology solutions.